SMC4 was found to be significantly related to poorer OS in sarcoma patients with reduced eosinophils, CD8+ T-cells, CD4+ memory T cells, B cells, basophils, natural killer T-cells, regulatory T-cells and type 2 T-helper cells. This evidence concerns the gene CD4 and sarcoma.